Genentech - South San Francisco, CA
posted 2 months ago
The Genentech Research and Early Development (gRED) Sr. Global Clinical Trial Leader (Sr. CTL) is a pivotal role responsible for the strategic planning, execution, and delivery of one or more early development global clinical trials. This position requires a seasoned leader who can drive study strategy and lead cross-functional global teams while managing overseas vendors. The Sr. CTL is expected to proactively manage risks and champion change, ensuring that complex programs focusing on the rapid development of new molecular entities are executed effectively, even in the absence of extensive clinical data. This necessitates the implementation of novel and highly flexible global operational strategies. In this role, you will lead cross-functional Protocol Execution Teams (PETs) through all stages of the study to achieve clinical development goals. You will inspire and influence teams to foster a positive and innovative work environment while promoting accountability both globally and locally. Your oversight will extend to critical clinical trial activities, including vendor management, drug supply, monitoring plans, and biomarker sample management. Collaboration with Clinical Science will be essential to provide operational input on protocol design, feasibility, and execution. You will play a key role in country and site selection, study-specific patient recruitment, and ensuring that study milestones are met on time. Additionally, you will manage the overall study budget and resources, identifying risks and developing mitigation strategies in collaboration with PET teams. Your leadership will contribute to operational expertise, process improvements, training, and strategic planning across gRED and Roche, making you an integral part of the clinical development process.